Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,086 | 186 | 99.5% |
| Education | $16.07 | 5 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $601.40 | 21 | $0 (2024) |
| Merck Sharp & Dohme LLC | $295.25 | 23 | $0 (2024) |
| ABBVIE INC. | $245.32 | 19 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $180.65 | 13 | $0 (2024) |
| Amarin Pharma Inc. | $180.45 | 11 | $0 (2021) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $164.98 | 10 | $0 (2024) |
| PFIZER INC. | $161.33 | 11 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $135.95 | 9 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $133.48 | 13 | $0 (2021) |
| Amgen Inc. | $122.70 | 9 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $698.88 | 33 | AstraZeneca Pharmaceuticals LP ($254.22) |
| 2023 | $722.45 | 32 | AstraZeneca Pharmaceuticals LP ($252.67) |
| 2022 | $452.13 | 30 | Boehringer Ingelheim Pharmaceuticals, Inc. ($133.43) |
| 2021 | $471.06 | 34 | AbbVie Inc. ($196.08) |
| 2020 | $201.26 | 15 | PFIZER INC. ($42.30) |
| 2019 | $159.62 | 12 | Amarin Pharma Inc. ($61.16) |
| 2018 | $186.82 | 14 | Sunovion Pharmaceuticals Inc. ($43.07) |
| 2017 | $210.27 | 21 | Merck Sharp & Dohme Corporation ($37.37) |
All Payment Transactions
191 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/07/2024 | Davol Inc. | Phasix Mesh (Device) | Food and Beverage | In-kind items and services | $54.51 | General |
| Category: Surgery | ||||||
| 10/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: DIABETES | ||||||
| 10/08/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $17.33 | General |
| Category: Respiratory | ||||||
| 10/03/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: Gastroenterology | ||||||
| 09/30/2024 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Food and Beverage | In-kind items and services | $23.53 | General |
| Category: Rare Disease | ||||||
| 09/26/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $21.46 | General |
| Category: Gastroenterology | ||||||
| 09/26/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $19.28 | General |
| Category: PSYCHIATRY | ||||||
| 09/24/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: Respiratory | ||||||
| 09/13/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: DIABETES | ||||||
| 09/12/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $19.56 | General |
| Category: Gastroenterology | ||||||
| 08/15/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: RESPIRATORY | ||||||
| 08/09/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $22.99 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/08/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: PSYCHIATRY | ||||||
| 07/19/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/17/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: Gastroenterology | ||||||
| 07/09/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $13.37 | General |
| Category: PSYCHIATRY | ||||||
| 06/21/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: Respiratory | ||||||
| 05/14/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 05/13/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $14.86 | General |
| Category: PSYCHIATRY | ||||||
| 05/10/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/09/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: Diabetes | ||||||
| 05/03/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.30 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/30/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $22.84 | General |
| Category: Respiratory | ||||||
| 04/12/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 48 | 4,731 | 9,713 | $625,208 | $394,653 |
| 2022 | 50 | 4,778 | 9,755 | $611,848 | $362,070 |
| 2021 | 50 | 4,848 | 10,240 | $624,182 | $381,936 |
| 2020 | 50 | 5,003 | 10,426 | $564,208 | $349,838 |
All Medicare Procedures & Services
198 procedure records from CMS Medicare Utilization — Page 1 of 8
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 349 | 885 | $139,830 | $66,767 | 47.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 262 | 1,001 | $86,086 | $60,567 | 70.4% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 135 | 428 | $45,368 | $34,248 | 75.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 195 | 308 | $38,192 | $28,127 | 73.6% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 142 | 166 | $32,702 | $22,642 | 69.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 183 | 183 | $25,071 | $22,176 | 88.5% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 67 | 248 | $20,088 | $12,471 | 62.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 78 | 81 | $19,683 | $10,755 | 54.6% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 40 | 219 | $16,425 | $9,879 | 60.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 85 | 96 | $16,128 | $9,423 | 58.4% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 320 | 683 | $14,343 | $8,908 | 62.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 344 | 988 | $9,880 | $8,249 | 83.5% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 337 | 764 | $13,752 | $7,866 | 57.2% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 101 | 101 | $8,075 | $7,651 | 94.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 74 | 82 | $10,332 | $7,204 | 69.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 90 | 125 | $15,000 | $6,773 | 45.2% |
| 99316 | Nursing facility discharge management, more than 30 minutes | Facility | 2023 | 71 | 84 | $9,070 | $6,664 | 73.5% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 87 | 99 | $9,405 | $6,011 | 63.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 42 | 50 | $11,050 | $5,999 | 54.3% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 38 | 38 | $8,170 | $5,974 | 73.1% |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2023 | 313 | 676 | $8,788 | $4,260 | 48.5% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 226 | 226 | $4,972 | $3,845 | 77.3% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 103 | 217 | $6,076 | $3,572 | 58.8% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Facility | 2023 | 28 | 34 | $5,270 | $3,469 | 65.8% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 15 | 16 | $4,480 | $3,341 | 74.6% |
About Dr. Sameh Youssef, M.D
Dr. Sameh Youssef, M.D is a Internal Medicine healthcare provider based in Cortland, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1023042850.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sameh Youssef, M.D has received a total of $3,102 in payments from pharmaceutical and medical device companies, with $698.88 received in 2024. These payments were reported across 191 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($3,086).
As a Medicare-enrolled provider, Youssef has provided services to 19,360 Medicare beneficiaries, totaling 40,134 services with total Medicare billing of $1.5M. Data is available for 4 years (2020–2023), covering 198 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Cortland, OH
- Active Since 07/10/2006
- Last Updated 04/20/2008
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1023042850
Products in Payments
- FARXIGA (Drug) $207.47
- AIRSUPRA (Drug) $182.46
- JARDIANCE (Drug) $181.34
- Vascepa (Drug) $180.45
- VERQUVO (Drug) $175.95
- XIFAXAN (Drug) $164.98
- REXULTI (Drug) $156.01
- VRAYLAR (Drug) $152.11
- BREZTRI (Drug) $140.58
- XARELTO (Drug) $135.95
- ENTRESTO (Drug) $80.22
- UBRELVY (Drug) $75.40
- ELIQUIS (Drug) $74.36
- LONHALA MAGNAIR (Drug) $70.11
- EVENITY (Biological) $68.49
- Phasix Mesh (Device) $54.51
- Kerendia (Drug) $46.33
- STRENSIQ (Biological) $44.11
- Veltassa (Drug) $40.85
- DIFICID (Drug) $40.52
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Cortland
Benjamin Kulper, M.d, M.D
Internal Medicine — Payments: $7,060
Dan Olson, M.d, M.D
Internal Medicine — Payments: $6,451
Mourad Rostom, M.d, M.D
Internal Medicine — Payments: $6,382
Sohair Rostom, M.d, M.D
Internal Medicine — Payments: $4,694
Mary Fontanarosa, M.d, M.D
Internal Medicine — Payments: $2,927
Dr. Zbigniew Lukawski, Md, MD
Internal Medicine — Payments: $1,942